Pauline du Rusquec

5PUBLICATIONS
32CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 15, 2026
SHIVA02 Trial: Using Patients as Their Own Controls to Assess Efficacy of Therapies Based on Molecular Profiling in Patients with Refractory Cancer.

|Aug 10, 2024
Real-World Survival Impact of New Treatment Strategies for Lung Cancer: A 2000-2020 French Cohort.

Clemence Basse, Matthieu Carton, Maud Milder

|Jul 02, 2021
Drug Development in Tissue-Agnostic Indications.

Pauline du Rusquec, Christophe Le Tourneau

|Jun 24, 2021
A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial.

Istvan Petak, Maud Kamal, Anna Dirner

|Dec 17, 2017
Efficacy of palbociclib plus fulvestrant after everolimus in hormone receptor-positive metastatic breast cancer.

Pauline du Rusquec, Clément Palpacuer, Loic Campion

Pageof 1

Frequent Collaborators

3 joint publications

Christophe Le Tourneau

2 joint publications

Vincent Servois

2 joint publications

Nicolas Servant

1 joint publications

Istvan Petak